Table 1.

Results of the nonparametric approach (Kruskal-Wallis test)

Rank of immunohistochemistrynIC50 against cisplatin (mean ± SE), mmol/L
7 (3 AC, 3 SC, 1 BC)4.52 ± 1.34 (1.00; 10.02; 6.68; 7.34; 1.94; 3.67; 1.00)
+7 (3 AC, 3 SC, 1 BC)11.70 ± 2.31 (5.91; 8.25; 10.35; 23.70; 7.04; 14.92; 11.75)
++8 (3 AC, 2 SC, 3 BC)34.42 ± 7.71 (18.60; 36.39; 40.06; 82.46; 40.73; 20.43; 19.03; 17.69)
+++5 (1 AC, 1 SC, 2 BC, 1 LC)522.66 ± 298.61 (837.94; 1,559.03; 75.78; 90.14; 50.41)
P < 0.001
  • Abbreviations: AC, adenocarcinoma; SC, squamous cell carcinoma; BC, bronchioloalveolar carcinoma; LC, large-cell carcinoma.